Report #2835380

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: UT
Recovered: Unknown
Vaccinated: Mar 17, 2025
Onset: Mar 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	941061	IM / LA

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

Administered an Expired Vaccine; Initial report received on 17-Mar-2025. A medical assistant reported that a 65-year-old female (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that had expired. No medical history or concomitant medications were reported. On 17-Mar-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number 941061, expiration date 10-Dec-2024, and NDC number 43528-003-05)] intramuscularly in the left arm. The patient was administered an expired vaccine. No adverse reactions were reported. No additional information was reported. Company Comment: ?The company assessed the event as non-serious.; Sender's Comments: ?The company assessed the event as non-serious.